Funder
diaDexus
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute
Subject
Cardiology and Cardiovascular Medicine
Reference48 articles.
1. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions;Hakkinen;Arterioscler. Thromb. Vasc. Biol.,1999
2. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor;MacPhee;Biochem. J.,1999
3. Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies;Thompson;Lancet,2011
4. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study;Oei;Circulation,2005
5. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease: west of scotland coronary prevention study group;Packard;N. Engl. J. Med.,2000
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献